rof. Ilja Striz, MD, PhD, Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
New Member Mini-Bios

Ilja Striz, MD, PhD, Head of the Department of Clinical and Transplant Immunology at the Institute for Clinical and Experimental Medicine (IKEM)

Ilja Striz serves as the head of the Department of Clinical and Transplant Immunology at the Institute for Clinical and Experimental Medicine (IKEM). He is also a Professor of Immunology at the 1st Medical Faculty of Charles University in Prague and holds the positions of Vice-President in the Czech Society of Allergology and Clinical Immunology and the Czech Immunological Society. [READ MORE]

ARINJAY BANERJEE, PhD (he/him)
New Member Mini-Bios

ARINJAY BANERJEE, PhD

Research within Dr. Banerjee’s laboratory focuses on three main themes that are inspired by the One Health ideology, (1) virus-host interactions in wildlife reservoir species, such as bats, (2) virus-host interactions in spillover species, such as humans, and (3) viral vaccine development. Dr. Banerjee’s laboratory is a member of Canada’s Coronavirus Variants Rapid Response Network (CoVaRR-Net), and as part of this network, his laboratory investigates emerging SARS-CoV-2 variants. Research within Dr. Banerjee’s laboratory is funded by NIAID/NIH, CIHR, NSERC, SHRF and CoVaRR-Net. [READ MORE]

New Member Mini-Bios

Esta Sterneck, PhD

Esta Sterneck , National Cancer Institute. Dr. Esta Sterneck received her Ph.D. from the University of Heidelberg following training at the European Molecular Biology Laboratory (EMBL) and the Center for Molecular Biology Heidelberg (ZMBH) in Germany. Her thesis work investigated oncogene cooperation in leukemia cells and revealed their coordinate induction of an essential autocrine growth factor. During her postdoctoral training at the Advanced BioScience Laboratories-Basic Research Program in Frederick, MD, USA, Dr. Sterneck began to study the functions of C/EBP transcription factors through genetically engineered mice. Dr. Sterneck began her independent research with an National Cancer Institute Scholar grant before being recruited as a Principal Investigator to the NCI in 2003. Her laboratory conducts basic research on the molecular biology of breast cancer development and progression with C/EBP transcription factors as pivots for mechanistic studies. Recent investigations involve the contributions of myeloid cell plasticity and tumor-induced myelopoiesis. [READ MORE]

Loading